Zhu et al. have demonstrated that IGF-1 enhances the expression of VEGF-C via the PI3K/Akt and MAPK/ERK1/2 signaling pathways in MDA-MB-231 breast cancer cells. The gene discussed is AKT1; the disease is breast cancer.